A growing faction of affluent, older New Yorkers who have left the city are buying second properties back home to anchor themselves to elite medical specialists. These med-à-terres are a safety net for seniors who are finding that, while they can export wealth, they can’t easily duplicate relationships with top-tier oncologists or cardiologists.

The Health newsletter takes you inside what’s new in health, medicine and personal well-being. If you’re not subscribed, sign up here.

Eye movement desensitization and reprocessing, or EMDR, is so mysterious that even its trained practitioners don’t fully understand how it works. Michael Waldholz, a Pulitzer Prize-winning former WSJ journalist, wrote about how EMDR healed his trauma.

Nancy Flury Carlson and Debbie Holecko met in third grade and have remained in regular contact as best friends since then—even though they haven’t lived in the same state for 60 years. That level of intimacy and emotional support is often what sets women’s friendships apart, writes Clare Ansberry.

Powerful new cholesterol-lowering drugs are on the horizon. Novartis and Ionis Pharmaceuticals expect results in the coming months for a drug targeting lipoprotein(a), a cause of heart disease. Amgen and Eli Lilly are also developing drugs targeting the particle.

Flavored vapes are becoming more readily available after recent FDA moves reversed a longstanding crackdown. The WSJ broke down what you should know about the risks of vaping.

U.S. towns paid for teachers and cops to use weight-loss drugs. It broke the bank. After more employees were prescribed the drugs than expected, some towns are now gearing up to strip coverage of GLP-1s for weight loss when their fiscal years end next month.

How many suspected Ebola cases had been identified as of Tuesday, including 223 suspected deaths in Congo, and seven cases with one death in Uganda, according to the WHO. Here’s what to know about the ebola outbreak, which is already the third largest ever.

• These thyroid disorder symptoms are easy to mistake for normal aging. (The Washington Post)

• What happens when your employer knows the diseases you might get? (The New York Times)

• Blood pressure tech floods the market after FDA relaxes wearables oversight. (STAT News)

The Health newsletter is your weekly guide to all the news that affects your health and well-being. This edition was curated and edited by Conor Grant—send him feedback or questions at conor.grant@wsj.com (if you’re reading this in your inbox, you can just hit reply). Got a tip for us? Here’s how to submit.